Atlas Trials

A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma

Clinical trial NCT02050321 · TERMINATED

Trial details

NCT number
NCT02050321
Sponsor
University of Arizona
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Malignant Melanoma
Start date
2013-12-01
Primary completion
2014-12-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.